The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Ketamine for refractory chronic pain: a 1-year follow-up study
Abstract
Ketamine is often used in pain clinics for refractory chronic pain, but its long-term efficacy is poorly reported. The main objective was to assess the long-term effect of ketamine on pain and health variables in patients with refractory chronic pain. A prospective, multicenter, 1-year follow-up observational study (NCT03319238) was conducted in 30 French pain clinics where ketamine is commonly prescribed. This study focused on patients with 1 ketamine delivery procedure (n = 256). The primary endpoint was pain intensity (0-10 numerical pain rating scale) before and after ketamine every month for 1 year. Secondary outcomes aimed to identify pain trajectories by semiparametric mixture models and to collect adverse events. The following data were obtained for 256 patients: Pain intensity decreased significantly (6.8 ± 1.8, n = 240 at baseline vs 5.7 ± 1.8, n = 93 at 12 months; P < 0.001). The effect size of the main endpoint was 0.61 (95% confidence interval: [0.40-0.80]; P < 0.001). Three pain trajectories were identified: 16.0% of patients in “mild pain” (mostly neuropathic pain), 35.3% in “moderate pain,” and 45.7% in “severe pain” (mostly fibromyalgia) trajectory. Neuropathic pain and fibromyalgia presented opposite outcomes, pain severity being associated with anxiety, depression, and a poorer quality of life. Adverse events occurred at 1 week in 108/218 [50%] patients, and this rate gradually decreased throughout the follow-up. This real-life study in chronic pain identified distinct pain trajectories and predictive variables of ketamine efficacy. It is now pivotal to further study and optimize the subtyping of patients to provide the most effective and safe ketamine treatment in this vulnerable population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the authors identified distinct pain trajectories and responses to ketamine for different forms of chronic pain”
From Ketamine in neuropsychiatric disorders: an update (2024) · cites this paper as [132]
In the citing paper
“a multicenter prospective trial (n = 256) found significant pain improvements at one-year follow-up [132]”
From Ketamine in neuropsychiatric disorders: an update (2024) · cites this paper as [132]
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
Treede, R.-D., Rief, W., Barke, A., Aziz, Q., Bennett, M. I., Benoliel, R., Cohen, M., Evers, S., Finnerup, N. B., First, M. B., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001384 · Cited by 3,478
Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries
Gandek, B., Ware, J. E., Aaronson, N. K., Apolone, G., Bjorner, J. B., Brazier, J. E., Bullinger, M., Kaasa, S., Leplege, A., Prieto, L., et al. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00109-7 · Cited by 2,907
A classification of chronic pain for ICD-11
Treede, R.-D., Rief, W., Barke, A., Aziz, Q., Bennett, M. I., Benoliel, R., Cohen, M., Evers, S., Finnerup, N. B., First, M. B., et al. (2015) · Pain · doi:10.1097/j.pain.0000000000000160 · Cited by 2,822
Group-Based Trajectory Modeling in Clinical Research
Nagin, D. S., & Odgers, C. L. (2010) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.121208.131413 · Cited by 2,708
Algorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles
Baron, R., Maier, C., Attal, N., Binder, A., Bouhassira, D., Cruccu, G., Finnerup, N. B., Haanpää, M., Hansson, P., Hüllemann, P., et al. (2017) · Pain · doi:10.1097/j.pain.0000000000000753 · Cited by 611
Schwenk, E. S., Viscusi, E. R., Buvanendran, A., Hurley, R. W., Wasan, A. D., Narouze, S., Bhatia, A., Davis, F. N., Hooten, W. M., & Cohen, S. P. (2018) · Regional Anesthesia and Pain Medicine · doi:10.1097/aap.0000000000000806 · Cited by 584
Research works printed but not linked: 1
- Sunanda, 2016, Marascuilo method of multiple comparisons (an analytical study of caesarean section delivery), Int J Contemp Med Res, 3, 1137
Cited by
Ketamine in neuropsychiatric disorders: an update
Johnston, J. N., Kadriu, B., Kraus, C., Henter, I. D., & Zarate, C. A. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-023-01632-1 · Cited by 108
“However, a multicenter prospective trial ( n = 256) found signi fi cant pain improvements at one-year follow-up [132].”
BackgroundNarrative Review: Low-Dose Ketamine for Pain Management
Riccardi, A., Guarino, M., Serra, S., Spampinato, M. D., Vanni, S., Shiffer, D., Voza, A., Fabbri, A., & Iaco, F. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093256 · Cited by 89
“However, it is unclear which patients or types of pain benefit most from an analgesic dose of ketamine [228,229].”
BackgroundKetamine in chronic pain: A Delphi survey
Voute, M., Riant, T., Amodéo, J., André, G., Barmaki, M., Collard, O., Colomb, C., Créac’h, C., Deleens, R., Delorme, C., et al. (2022) · European Journal of Pain · doi:10.1002/ejp.1914 · Cited by 28
“Moreover, the majority of experts participated as co- investigators of a national observational study in patients with chronic pain (OKAPINCT033119238, Corriger et al., 2021).”
BackgroundSelf-citationVoute, M., Lambert, C., Pereira, B., & Pickering, G. P. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.14406 · Cited by 21
Self-citationElyn, A., Roussin, A., Lestrade, C., Franchitto, N., Jullian, B., & Cantagrel, N. (2024) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2023-105035 · Cited by 15
Metadata
- Authors
- Corriger, A., Voute, M., Lambert, C., Pereira, B., & Pickering, G.
- Affiliations
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
- University Hospital Clermont-Ferrand, Clinical Pharmacology Center, Clermont-Ferrand, France
- Venue
- Pain
- Published
- 2021-07-20
- Volume
- 163
- Issue
- 4
- Pages
- 690-701
- ISSN
- 0304-3959 (ISSN-L)
- 1872-6623
- OpenAlex
- W3182373336
- Cited by
- 31
- References
- 41
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 3 · 2023: 10 · 2022: 4
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pain (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Keywords
- ketamine, refractory chronic pain, long-term efficacy, pain intensity, pain trajectories, neuropathic pain, fibromyalgia, anxiety, depression, quality of life, adverse events, patient subtyping, pain clinic
- MeSH terms
- Fibromyalgia, Follow-Up Studies, Humans, Ketamine, Neuralgia, Prospective Studies, Quality of Life, Chronic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ketamine for refractory chronic pain: a 1-year follow-up study. https://app.cochat.ai/papers/10.1097/j.pain.0000000000002403
- The paper
- Corriger, A., Voute, M., Lambert, C., Pereira, B., & Pickering, G. (2022). Ketamine for refractory chronic pain: a 1-year follow-up study. Pain. https://doi.org/10.1097/j.pain.0000000000002403
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.